Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Revenue

Neurocrine Biosciences had revenue of $1.98B in the twelve months ending March 31, 2024, with 23.99% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $515.30M with 22.57% year-over-year growth. In the year 2023, Neurocrine Biosciences had annual revenue of $1.89B with 26.76% growth.

• Revenue (ttm): $1.98B
• Revenue Growth: +23.99%
• P/S Ratio: 7.18
• Revenue / Employee: $1,415,714
• Employees: 1,400
• Market Cap: 14.23B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.89B	398.40M	26.76%
Dec 31, 2022	1.49B	355.20M	31.34%
Dec 31, 2021	1.13B	87.60M	8.38%
Dec 31, 2020	1.05B	257.80M	32.71%
Dec 31, 2019	788.10M	336.90M	74.67%
Dec 31, 2018	451.20M	289.57M	179.16%
Dec 31, 2017	161.63M	146.63M	977.51%
Dec 31, 2016	15.00M	-4.77M	-24.12%
Dec 31, 2015	19.77M	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	2.92M	-50.22M	-94.51%
Dec 31, 2012	53.14M	-24.27M	-31.36%
Dec 31, 2011	77.41M	43.91M	131.08%
Dec 31, 2010	33.50M	30.55M	1,034.47%
Dec 31, 2009	2.95M	-1.02M	-25.71%
Dec 31, 2008	3.98M	2.75M	224.75%
Dec 31, 2007	1.22M	-38.01M	-96.88%
Dec 31, 2006	39.23M	-84.66M	-68.33%
Dec 31, 2005	123.89M	38.71M	45.45%
Dec 31, 2004	85.18M	-53.90M	-38.76%
Dec 31, 2003	139.08M	121.03M	670.73%
Dec 31, 2002	18.05M	-23.20M	-56.25%
Dec 31, 2001	41.24M	26.65M	182.71%
Dec 31, 2000	14.59M	-2.20M	-13.12%
Dec 31, 1999	16.79M	754.00K	4.70%
Dec 31, 1998	16.04M	-10.11M	-38.66%
Dec 31, 1997	26.14M	6.93M	36.05%
Dec 31, 1996	19.22M	13.11M	214.72%
Dec 31, 1995	6.11M	5.94M	3,679.88%
Dec 31, 1994	161.53K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.